Solid Organ Transplant (SOT) Market
Solid Organ Transplant (SOT) Market Study by Kidney, Liver, Pancreas, Heart, Lung, and Small Bowel for Infants/Pediatrics and Adults from 2024 to 2034
Analysis of Solid Organ Transplant (SOT) Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Solid Organ Transplant (SOT) Market Outlook (2024 to 2034)
The global solid organ transplant (SOT) market is estimated at US$ 4.9 billion in 2024 and has been forecasted to increase at a CAGR of 4.9% to reach US$ 7.88 billion by the end of 2034.
Since early ages, people have faced problems in their organs that are sometimes fatal and can lead to death. As a result, transplantation techniques were introduced as technology advanced, and the emergence of solid organ transplants has taken things a step further. Growing requirements for these procedures and the introduction of new and more efficient techniques are driving overall solid organ transplant market growth.
- In the United Kingdom, the National Health Service is carrying out regular public awareness to make people understand and encourage them to register for organ donations. These programs are increasing the popularity of organ donations across the country.
- In the year 2022, a fundraising event was organized by the American Transplant Foundation. This program advertised and promoted public awareness related to various organ donations and transplantation.
- In the Middle East and Africa region, the market is showing potential to progress at a CAGR of 4.8%, which is even higher than in Eastern Europe. This has allowed research organizations to expand their business in this region.
| Report Attributes | Details |
|---|---|
| Solid Organ Transplant (SOT) Market Size (2024E) | US$ 4.9 Billion |
| Forecasted Market Value (2034F) | US$ 7.88 Billion |
| Global Market Growth Rate (2024 to 2034) | 4.9% CAGR |
| East Asia Market Share (2024E) | 13.7% |
| North America Market Growth Rate (2024 to 2034) | 5.8% CAGR |
| Alkylating Agents Segment Value (2034F) | 268.2 Million |
| mTOR Inhibitors Segment Value (2034F) | US$ 1.26 Billion |
| Key Companies Profiled | Astellas Pharma US, Inc.; Bristol-Myers Squibb Company; AbbVie Inc.; Amneal Pharmaceuticals, Inc.; Asahi Kasei Pharma Corporation; Azurity Pharmaceuticals, Inc.; Bausch Health Companies Inc.; Genentech USA, Inc.; Glenmark Pharmaceuticals Inc., USA; Novartis; Pfizer Inc.; Sanofi S.A.; F. Hoffmann-La Roche AG |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Why is the Solid Organ Transplant Market Size Expanding at a Steady Rate?
“Huge Waiting List of Organ Recipients”
One of the primary drivers that are helping research organizations and hospitals make huge profits is the significant increase in transplantation procedures around the world. More people are indulging in poor lifestyle choices such as drinking and smoking, even though they are aware of their ill effects. These poor lifestyle choices have increased the incidence of organ failure and other health issues. Chronic illnesses, including cancer, kidney failure, COPD, and lupus, often result in damage to tissues and organs.
Several governments are focusing on increasing awareness about the benefits of organ donation, which can help people who are in need since the lack of organs is a key concern.
“Introduction of 3D-Printed Organs”
Advent of 3D printers has opened a new gate of possibilities in the medical field. Printing of organs has now become a real possibility, and this is a big help when there are no organ donors available when needed. An emerging technology in 3D tissue products is autologous stem cell transplant, which has become popular due to the introduction of induced pluripotent stem cells. Doctors and scientists alike are looking to develop organs from human-induced pluripotent stem cells.
- BioFibr, known for its innovative technological products, launched a bio-ink additive in June 2023, called μCollaFibR and CollaFibR 3D scaffold. This new fiber product is becoming common in the bioprinting of tissue and organ models.
Country-wise Analysis
Health issues are somewhat global and every country is trying its best to advance its healthcare system. The United States, Canada, Eastern Europe, Western Europe, and South Korea and some of the key markets in this landscape. East Asia and North America are foreseen to hold significant solid organ transplant market shares over the next ten years.
What is Becoming a Success Factor for Healthcare Professionals in India?
“Private and Public Institutions Coming Together to Reduce Waiting Period”
| Attribute | India |
|---|---|
| Market Value (2024E) | US$ 243.6 Million |
| Growth Rate (2024 to 2034) | 7% CAGR |
| Projected Value (2034F) | US$ 478.2 Million |
India is a developing country and it becomes very important for the government to keep a close connection with private institutions to solve major issues to become a strong and developed country. The government in India has identified how the prolonged waiting time can lead to a severe loss of both money and life. It has introduced various programs where common people are made aware of organ donations on a large scale. More people are understanding the importance of this and how they can save the lives of fellow citizens. As a result, the waiting time for patients has reduced significantly, though much more needs to be done over the coming years.
- The National Organ Transplant Programme (NOTP) is a program by the Government of India that aims to promote organ donation and transplantation across the country, which was introduced in the year 2021.
What is the Market Situation for Solid Organ Transplants in the United States?
“Implementation of Telemedicine and AI integration”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 1.74 Billion |
| Growth Rate (2024 to 2034) | 5.6% CAGR |
| Projected Value (2034F) | US$ 3 Billion |
The United States is always known for its early technological moves in many fields, including healthcare. The country has understood the potential of AI and is figuring out how it can improve surgical procedures and therapies to decrease the recovery time of patients. Key healthcare professionals in the country have also started to use telemedicine, which is a technique to enable remote patient evaluation, enhancing access to transplant services, especially for those in remote areas or accident spots. This is widening the market possibilities for solid organ transplants across the whole country.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Category-wise Examination
The market has been segmented into various categories according to therapies and drugs involved in the healing process. These include drug class, therapy type, and distribution channels.
Which Type of Therapy is Preferred for Solid Organ Transplants?
“Targeted Immunosuppressive Therapy More Desirable Compared to Other Therapies”
| Attribute | Targeted Immunosuppressive Therapy |
|---|---|
| Segment Value (2024E) | US$ 2.71 Billion |
| Growth Rate (2024 to 2034) | 4.7% CAGR |
| Projected Value (2034F) | US$ 4.29 Billion |
Patients are increasingly favoring targeted immunosuppressive therapies over other treatments for solid organ transplants. This preference stems from the potential benefits and improved outcomes associated with targeted immunosuppressive therapies, making them more desirable compared to traditional options. Professional institutions are hiring doctors who have a specialty in these therapies to attract more patients to their hospitals, leading to steady growth in profits.
Which Drugs are Proven to Be More Effective During Recovery?
“Calcineurin Inhibitors Highly Effective in Treatment and Recovery”
| Attribute | Calcineurin Inhibitors |
|---|---|
| Segment Value (2024E) | US$ 1.81 Billion |
| Growth Rate (2024 to 2034) | 5.4% CAGR |
| Projected Value (2034F) | US$ 3.06 Billion |
Calcineurin inhibitors have demonstrated their effectiveness and have gained popularity among patients during organ transplantation recovery. These inhibitors are highly favored by patients due to their ability to effectively facilitate the healing process, thereby contributing to better recovery outcomes and patient satisfaction. This is a key solid organ transplant market trend that is here to stay for many more years to come.
Competitive Landscape
Key players in the solid organ transplant market are also focusing on introducing new products, including artificial eyes and artificial kidneys.
- TransMedics, to expand its business base, acquired Bridge to Life Ltd in August 2023 for technologies, including the LifeCradle Heart Preservation Transport System. This purchase will expand its product offering for organ transplants, making the company stronger in the market
- MediGO and LiveonNY, two big medical firms collaborated in March 2023 and introduced a real-time organ tracking technology. This technology helps in keeping track of organ donations and transplantation.
- In July 2022, Precise Bio and Carl Zeiss came together to work and develop commercialized fabricated corneal tissue for patients in their hospitals and natural lenticular transplants to treat keratoconus and vision correction.
Fact.MR provides detailed information about the price points of prominent players in the solid organ transplant market positioned across the world, sales growth, production capacity, and speculative technological expansion, in this new market report.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Segmentation of SOT Market Research
-
By Therapy:
- Immunomodeulatory Therapies
- Biomarket-Driven Therapies
- Targeted Immunosuppressive Therapies
-
By Drug Class:
- Alkylating Agents
- Calcineurin Inhibitors
- Interleukin Inhibitors
- mTOR Inhibitors
- Antiproliferative Agents
- Steroids
- Other Drug Class
-
By Organ Type:
- Kidneys
- Liver
- Pancreas
- Heart
- Lungs
- Small Bowel
- Other Solid Organs
-
By Age Group:
- Infants/Pediatrics
- Adults
-
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
-
By End User:
- Hospitals
- Transplant Centres
- Ambulatory Surgical Centres
- Academic & Research Centres
-
By Region:
- North America
- Western Europe
- Eastern Europe
- Latin America
- East Asia
- South Asia & Pacific
- Middle East & Africa
Table of Content
- 1. Executive Summary
- 2. Industry Introduction, including Taxonomy and Market Definition
- 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
- 4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections
- 5. Pricing Analysis
- 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034
- 6.1. Therapy
- 6.2. Drug Class
- 6.3. Organ
- 6.4. Age Group
- 6.5. Distribution Channel
- 6.6. End User
- 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Therapy
- 7.1. Immunomodeulatory Therapies
- 7.2. Biomarket-Driven Therapies
- 7.3. Targeted Immunosuppressive Therapies
- 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Drug Class
- 8.1. Alkylating Agents
- 8.2. Calcineurin Inhibitors
- 8.3. Interleukin Inhibitors
- 8.4. mTOR Inhibitors
- 8.5. Antiproliferative Agents
- 8.6. Steroids
- 8.7. Other Drug Class
- 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Organ
- 9.1. Kidneys
- 9.2. Liver
- 9.3. Pancreas
- 9.4. Heart
- 9.5. Lungs
- 9.6. Small Bowel
- 9.7. Other Solid Organs
- 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Age Group
- 10.1. Infants/Pediatrics
- 10.2. Adults
- 11. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Distribution Channel
- 11.1. Hospital Pharmacies
- 11.2. Retail Pharmacies
- 11.3. Online Pharmacies
- 11.4. Other Distribution Channels
- 12. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by End User
- 12.1. Hospitals
- 12.2. Transplant Centres
- 12.3. Ambulatory Surgical Centres
- 12.4. Academic & Research Centres
- 13. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Region
- 13.1. North America
- 13.2. Latin America
- 13.3. Western Europe
- 13.4. Eastern Europe
- 13.5. East Asia
- 13.6. South Asia & Pacific
- 13.7. Middle East & Africa
- 14. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 15. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 16. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 17. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 18. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 19. South Asia & Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 20. Middle East & Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 21. Sales Forecast 2024 to 2034 by Therapy, Drug Class, Organ, Age Group, Distribution Channel, End User, and Region for 30 Countries
- 22. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
- 23. Company Profile
- 23.1. Astellas Pharma US, Inc.
- 23.2. Bristol-Myers Squibb Company
- 23.3. AbbVie Inc.
- 23.4. Amneal Pharmaceuticals, Inc.
- 23.5. Asahi Kasei Pharma Corporation
- 23.6. Azurity Pharmaceuticals, Inc.
- 23.7. Bausch Health Companies Inc.
- 23.8. Genentech USA, Inc.
- 23.9. Glenmark Pharmaceuticals Inc., USA
- 23.10. Novartis
- 23.11. Pfizer Inc.
- 23.12. Sanofi S.A.
- 23.13. F. Hoffmann-La Roche AG
- 24. Assumptions and Acronyms Used
- 25. Research End Userology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Market Value (US$ Mn) Analysis, by Therapy, 2019 to 2023
Table 2: Global Market Value (US$ Mn) Analysis, by Therapy, 2024 to 2034
Table 3: Global Market Value (US$ Mn) Opportunity Analysis, by Therapy, 2024 to 2034
Table 4: Global Market Value (US$ Mn) Analysis, by Drug Class, 2019 to 2023
Table 5: Global Market Value (US$ Mn) Analysis, by Drug Class, 2024 to 2034
Table 6: Global Market Value (US$ Mn) Opportunity Analysis, by Drug Class, 2024 to 2034
Table 7: Global Market Value (US$ Mn) Analysis, by Organ, 2019 to 2023
Table 8: Global Market Value (US$ Mn) Analysis, by Organ, 2024 to 2034
Table 9: Global Market Value (US$ Mn) Opportunity Analysis, by Organ, 2024 to 2034
Table 10: Global Market Value (US$ Mn) Analysis, by Age Group, 2019 to 2023
Table 11: Global Market Value (US$ Mn) Analysis, by Age Group, 2024 to 2034
Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by Age Group, 2024 to 2034
Table 13: Global Market Value (US$ Mn) Analysis, by Distribution Channel, 2019 to 2023
Table 14: Global Market Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034
Table 15: Global Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2024 to 2034
Table 16: Global Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 17: Global Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 18: Global Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 19: Global Market Value (US$ Mn) Analysis, by Region, 2019 to 2023
Table 20: Global Market Value (US$ Mn) Analysis, by Region, 2024 to 2034
Table 21: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2024 to 2034
Table 22: North America Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 23: North America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 25: North America Market Value (US$ Mn) Analysis, by Therapy, 2019 to 2023
Table 26: North America Market Value (US$ Mn) Analysis, by Therapy, 2024 to 2034
Table 27: North America Market Value (US$ Mn) Opportunity Analysis, by Therapy, 2024 to 2034
Table 28: North America Market Value (US$ Mn) Analysis, by Drug Class, 2019 to 2023
Table 29: North America Market Value (US$ Mn) Analysis, by Drug Class, 2024 to 2034
Table 30: North America Market Value (US$ Mn) Opportunity Analysis, by Drug Class, 2024 to 2034
Table 31: North America Market Value (US$ Mn) Analysis, by Organ, 2019 to 2023
Table 32: North America Market Value (US$ Mn) Analysis, by Organ, 2024 to 2034
Table 33: North America Market Value (US$ Mn) Opportunity Analysis, by Organ, 2024 to 2034
Table 34: North America Market Value (US$ Mn) Analysis, by Age Group, 2019 to 2023
Table 35: North America Market Value (US$ Mn) Analysis, by Age Group, 2024 to 2034
Table 36: North America Market Value (US$ Mn) Opportunity Analysis, by Age Group, 2024 to 2034
Table 37: North America Market Value (US$ Mn) Analysis, by Distribution Channel, 2019 to 2023
Table 38: North America Market Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034
Table 39: North America Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2024 to 2034
Table 40: North America Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 41: North America Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 42: North America Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 43: Latin America Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 44: Latin America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 45: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 46: Latin America Market Value (US$ Mn) Analysis, by Therapy, 2019 to 2023
Table 47: Latin America Market Value (US$ Mn) Analysis, by Therapy, 2024 to 2034
Table 48: Latin America Market Value (US$ Mn) Opportunity Analysis, by Therapy, 2024 to 2034
Table 49: Latin America Market Value (US$ Mn) Analysis, by Drug Class, 2019 to 2023
Table 50: Latin America Market Value (US$ Mn) Analysis, by Drug Class, 2024 to 2034
Table 51: Latin America Market Value (US$ Mn) Opportunity Analysis, by Drug Class, 2024 to 2034
Table 52: Latin America Market Value (US$ Mn) Analysis, by Organ, 2019 to 2023
Table 53: Latin America Market Value (US$ Mn) Analysis, by Organ, 2024 to 2034
Table 54: Latin America Market Value (US$ Mn) Opportunity Analysis, by Organ, 2024 to 2034
Table 55: Latin America Market Value (US$ Mn) Analysis, by Age Group, 2019 to 2023
Table 56: Latin America Market Value (US$ Mn) Analysis, by Age Group, 2024 to 2034
Table 57: Latin America Market Value (US$ Mn) Opportunity Analysis, by Age Group, 2024 to 2034
Table 58: Latin America Market Value (US$ Mn) Analysis, by Distribution Channel, 2019 to 2023
Table 59: Latin America Market Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034
Table 60: Latin America Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2024 to 2034
Table 61: Latin America Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 62: Latin America Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 63: Latin America Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 64: Western Europe Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 65: Western Europe Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 66: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 67: Western Europe Market Value (US$ Mn) Analysis, by Therapy, 2019 to 2023
Table 68: Western Europe Market Value (US$ Mn) Analysis, by Therapy, 2024 to 2034
Table 69: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Therapy, 2024 to 2034
Table 70: Western Europe Market Value (US$ Mn) Analysis, by Drug Class, 2019 to 2023
Table 71: Western Europe Market Value (US$ Mn) Analysis, by Drug Class, 2024 to 2034
Table 72: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Drug Class, 2024 to 2034
Table 73: Western Europe Market Value (US$ Mn) Analysis, by Organ, 2019 to 2023
Table 74: Western Europe Market Value (US$ Mn) Analysis, by Organ, 2024 to 2034
Table 75: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Organ, 2024 to 2034
Table 76: Western Europe Market Value (US$ Mn) Analysis, by Age Group, 2019 to 2023
Table 77: Western Europe Market Value (US$ Mn) Analysis, by Age Group, 2024 to 2034
Table 78: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Age Group, 2024 to 2034
Table 79: Western Europe Market Value (US$ Mn) Analysis, by Distribution Channel, 2019 to 2023
Table 80: Western Europe Market Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034
Table 81: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2024 to 2034
Table 82: Western Europe Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 83: Western Europe Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 84: Western Europe Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 85: Eastern Europe Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 86: Eastern Europe Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 87: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 88: Eastern Europe Market Value (US$ Mn) Analysis, by Therapy, 2019 to 2023
Table 89: Eastern Europe Market Value (US$ Mn) Analysis, by Therapy, 2024 to 2034
Table 90: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Therapy, 2024 to 2034
Table 91: Eastern Europe Market Value (US$ Mn) Analysis, by Drug Class, 2019 to 2023
Table 92: Eastern Europe Market Value (US$ Mn) Analysis, by Drug Class, 2024 to 2034
Table 93: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Drug Class, 2024 to 2034
Table 94: Eastern Europe Market Value (US$ Mn) Analysis, by Organ, 2019 to 2023
Table 95: Eastern Europe Market Value (US$ Mn) Analysis, by Organ, 2024 to 2034
Table 96: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Organ, 2024 to 2034
Table 97: Eastern Europe Market Value (US$ Mn) Analysis, by Age Group, 2019 to 2023
Table 98: Eastern Europe Market Value (US$ Mn) Analysis, by Age Group, 2024 to 2034
Table 99: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Age Group, 2024 to 2034
Table 100: Eastern Europe Market Value (US$ Mn) Analysis, by Distribution Channel, 2019 to 2023
Table 101: Eastern Europe Market Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034
Table 102: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2024 to 2034
Table 103: Eastern Europe Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 104: Eastern Europe Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 105: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 106: East Asia Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 107: East Asia Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 108: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 109: East Asia Market Value (US$ Mn) Analysis, by Therapy, 2019 to 2023
Table 110: East Asia Market Value (US$ Mn) Analysis, by Therapy, 2024 to 2034
Table 111: East Asia Market Value (US$ Mn) Opportunity Analysis, by Therapy, 2024 to 2034
Table 112: East Asia Market Value (US$ Mn) Analysis, by Drug Class, 2019 to 2023
Table 113: East Asia Market Value (US$ Mn) Analysis, by Drug Class, 2024 to 2034
Table 114: East Asia Market Value (US$ Mn) Opportunity Analysis, by Drug Class, 2024 to 2034
Table 115: East Asia Market Value (US$ Mn) Analysis, by Organ, 2019 to 2023
Table 116: East Asia Market Value (US$ Mn) Analysis, by Organ, 2024 to 2034
Table 117: East Asia Market Value (US$ Mn) Opportunity Analysis, by Organ, 2024 to 2034
Table 118: East Asia Market Value (US$ Mn) Analysis, by Age Group, 2019 to 2023
Table 119: East Asia Market Value (US$ Mn) Analysis, by Age Group, 2024 to 2034
Table 120: East Asia Market Value (US$ Mn) Opportunity Analysis, by Age Group, 2024 to 2034
Table 121: East Asia Market Value (US$ Mn) Analysis, by Distribution Channel, 2019 to 2023
Table 122: East Asia Market Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034
Table 123: East Asia Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2024 to 2034
Table 124: East Asia Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 125: East Asia Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 126: East Asia Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 127: South Asia & Pacific Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 128: South Asia & Pacific Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 129: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 130: South Asia & Pacific Market Value (US$ Mn) Analysis, by Therapy, 2019 to 2023
Table 131: South Asia & Pacific Market Value (US$ Mn) Analysis, by Therapy, 2024 to 2034
Table 132: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Therapy, 2024 to 2034
Table 133: South Asia & Pacific Market Value (US$ Mn) Analysis, by Drug Class, 2019 to 2023
Table 134: South Asia & Pacific Market Value (US$ Mn) Analysis, by Drug Class, 2024 to 2034
Table 135: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Drug Class, 2024 to 2034
Table 136: South Asia & Pacific Market Value (US$ Mn) Analysis, by Organ, 2019 to 2023
Table 137: South Asia & Pacific Market Value (US$ Mn) Analysis, by Organ, 2024 to 2034
Table 138: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Organ, 2024 to 2034
Table 139: South Asia & Pacific Market Value (US$ Mn) Analysis, by Age Group, 2019 to 2023
Table 140: South Asia & Pacific Market Value (US$ Mn) Analysis, by Age Group, 2024 to 2034
Table 141: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Age Group, 2024 to 2034
Table 142: South Asia & Pacific Market Value (US$ Mn) Analysis, by Distribution Channel, 2019 to 2023
Table 143: South Asia & Pacific Market Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034
Table 144: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2024 to 2034
Table 145: South Asia & Pacific Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 146: South Asia & Pacific Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 147: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 148: MEA Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 149: MEA Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 150: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 151: MEA Market Value (US$ Mn) Analysis, by Therapy, 2019 to 2023
Table 152: MEA Market Value (US$ Mn) Analysis, by Therapy, 2024 to 2034
Table 153: MEA Market Value (US$ Mn) Opportunity Analysis, by Therapy, 2024 to 2034
Table 154: MEA Market Value (US$ Mn) Analysis, by Drug Class, 2019 to 2023
Table 155: MEA Market Value (US$ Mn) Analysis, by Drug Class, 2024 to 2034
Table 156: MEA Market Value (US$ Mn) Opportunity Analysis, by Drug Class, 2024 to 2034
Table 157: MEA Market Value (US$ Mn) Analysis, by Organ, 2019 to 2023
Table 158: MEA Market Value (US$ Mn) Analysis, by Organ, 2024 to 2034
Table 159: MEA Market Value (US$ Mn) Opportunity Analysis, by Organ, 2024 to 2034
Table 160: MEA Market Value (US$ Mn) Analysis, by Age Group, 2019 to 2023
Table 161: MEA Market Value (US$ Mn) Analysis, by Age Group, 2024 to 2034
Table 162: MEA Market Value (US$ Mn) Opportunity Analysis, by Age Group, 2024 to 2034
Table 163: MEA Market Value (US$ Mn) Analysis, by Distribution Channel, 2019 to 2023
Table 154: MEA Market Value (US$ Mn) Analysis, by Distribution Channel, 2024 to 2034
Table 165: MEA Market Value (US$ Mn) Opportunity Analysis, by Distribution Channel, 2024 to 2034
Table 166: MEA Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 167: MEA Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 168: MEA Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 2: Global Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 3: Global Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 4: Global Market Incremental $ Opportunity, 2024 to 2034
Figure 5: Global Market Share and BPS Analysis by Therapy, 2024 & 2034
Figure 6: Global Market Y-o-Y Growth Projections by Therapy, 2024 to 2034
Figure 7: Global Market Attractiveness Analysis by Therapy, 2024 to 2034
Figure 8: Global Market Share and BPS Analysis by Drug Class, 2024 & 2034
Figure 9: Global Market Y-o-Y Growth Projections by Drug Class, 2024 to 2034
Figure 10: Global Market Attractiveness Analysis by Drug Class, 2024 to 2034
Figure 11: Global Market Share and BPS Analysis by Organ, 2024 & 2034
Figure 12: Global Market Y-o-Y Growth Projections by Organ, 2024 to 2034
Figure 13: Global Market Attractiveness Analysis by Organ, 2024 to 2034
Figure 14: Global Market Share and BPS Analysis by Age Group, 2024 & 2034
Figure 15: Global Market Y-o-Y Growth Projections by Age Group, 2024 to 2034
Figure 16: Global Market Attractiveness Analysis by Age Group, 2024 to 2034
Figure 17: Global Market Share and BPS Analysis by Distribution Channel, 2024 & 2034
Figure 18: Global Market Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034
Figure 19: Global Market Attractiveness Analysis by Distribution Channel, 2024 to 2034
Figure 20: Global Market Share and BPS Analysis by End User, 2024 & 2034
Figure 21: Global Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 22: Global Market Attractiveness Analysis by End User, 2024 to 2034
Figure 23: Global Market Share and BPS Analysis by Region, 2024 & 2034
Figure 24: Global Market Y-o-Y Growth Projections by Region, 2024 to 2034
Figure 25: Global Market Attractiveness Analysis by Region, 2024 to 2034
Figure 26: North America Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 27: North America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 28: North America Market Value Y-o-Y Growth and Forecast, 2034
Figure 29: North America Market Incremental $ Opportunity, 2024 to 2034
Figure 30: North America Market Share Analysis by Country, 2024 & 2034
Figure 31: North America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 32: North America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 33: North America Market Share and BPS Analysis by Therapy, 2024 & 2034
Figure 34: North America Market Y-o-Y Growth Projections by Therapy, 2024 to 2034
Figure 35: North America Market Attractiveness Analysis by Therapy, 2024 to 2034
Figure 36: North America Market Share and BPS Analysis by Drug Class, 2024 & 2034
Figure 37: North America Market Y-o-Y Growth Projections by Drug Class, 2024 to 2034
Figure 38: North America Market Attractiveness Analysis by Drug Class, 2024 to 2034
Figure 39: North America Market Share and BPS Analysis by Organ, 2024 & 2034
Figure 40: North America Market Y-o-Y Growth Projections by Organ, 2024 to 2034
Figure 41: North America Market Attractiveness Analysis by Organ, 2024 to 2034
Figure 42: North America Market Share and BPS Analysis by Age Group, 2024 & 2034
Figure 43: North America Market Y-o-Y Growth Projections by Age Group, 2024 to 2034
Figure 44: North America Market Attractiveness Analysis by Age Group, 2024 to 2034
Figure 45: North America Market Share and BPS Analysis by Distribution Channel, 2024 & 2034
Figure 46: North America Market Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034
Figure 47: North America Market Attractiveness Analysis by Distribution Channel, 2024 to 2034
Figure 48: North America Market Share and BPS Analysis by End User, 2024 & 2034
Figure 49: North America Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 50: North America Market Attractiveness Analysis by End User, 2024 to 2034
Figure 51: Latin America Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 52: Latin America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 53: Latin America Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 54: Latin America Market Incremental $ Opportunity, 2024 to 2034
Figure 55: Latin America Market Share Analysis by Country, 2024 & 2034
Figure 56: Latin America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 57: Latin America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 59: Latin America Market Share and BPS Analysis by Therapy, 2024 & 2034
Figure 59: Latin America Market Y-o-Y Growth Projections by Therapy, 2024 to 2034
Figure 60: Latin America Market Attractiveness Analysis by Therapy, 2024 to 2034
Figure 61: Latin America Market Share and BPS Analysis by Drug Class, 2024 & 2034
Figure 62: Latin America Market Y-o-Y Growth Projections by Drug Class, 2024 to 2034
Figure 63: Latin America Market Attractiveness Analysis by Drug Class, 2024 to 2034
Figure 64: Latin America Market Share and BPS Analysis by Organ, 2024 & 2034
Figure 65: Latin America Market Y-o-Y Growth Projections by Organ, 2024 to 2034
Figure 66: Latin America Market Attractiveness Analysis by Organ, 2024 to 2034
Figure 67: Latin America Market Share and BPS Analysis by Age Group, 2024 & 2034
Figure 68: Latin America Market Y-o-Y Growth Projections by Age Group, 2024 to 2034
Figure 69: Latin America Market Attractiveness Analysis by Age Group, 2024 to 2034
Figure 70: Latin America Market Share and BPS Analysis by Distribution Channel, 2024 & 2034
Figure 71: Latin America Market Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034
Figure 72: Latin America Market Attractiveness Analysis by Distribution Channel, 2024 to 2034
Figure 73: Latin America Market Share and BPS Analysis by End User, 2024 & 2034
Figure 74: Latin America Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 75: Latin America Market Attractiveness Analysis by End User, 2024 to 2034
Figure 76: Western Europe Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 77: Western Europe Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 78: Western Europe Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 79: Western Europe Market Incremental $ Opportunity, 2024 to 2034
Figure 80: Western Europe Market Share Analysis by Country, 2024 & 2034
Figure 81: Western Europe Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 82: Western Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 83: Western Europe Market Share and BPS Analysis by Therapy, 2024 & 2034
Figure 84: Western Europe Market Y-o-Y Growth Projections by Therapy, 2024 to 2034
Figure 85: Western Europe Market Attractiveness Analysis by Therapy, 2024 to 2034
Figure 86: Western Europe Market Share and BPS Analysis by Drug Class, 2024 & 2034
Figure 87: Western Europe Market Y-o-Y Growth Projections by Drug Class, 2024 to 2034
Figure 88: Western Europe Market Attractiveness Analysis by Drug Class, 2024 to 2034
Figure 89: Western Europe Market Share and BPS Analysis by Organ, 2024 & 2034
Figure 90: Western Europe Market Y-o-Y Growth Projections by Organ, 2024 to 2034
Figure 91: Western Europe Market Attractiveness Analysis by Organ, 2024 to 2034
Figure 92: Western Europe Market Share and BPS Analysis by Age Group, 2024 & 2034
Figure 93: Western Europe Market Y-o-Y Growth Projections by Age Group, 2024 to 2034
Figure 94: Western Europe Market Attractiveness Analysis by Age Group, 2024 to 2034
Figure 95: Western Europe Market Share and BPS Analysis by Distribution Channel, 2024 & 2034
Figure 96: Western Europe Market Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034
Figure 97: Western Europe Market Attractiveness Analysis by Distribution Channel, 2024 to 2034
Figure 98: Western Europe Market Share and BPS Analysis by End User, 2024 & 2034
Figure 99: Western Europe Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 100: Western Europe Market Attractiveness Analysis by End User, 2024 to 2034
Figure 101: Eastern Europe Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 102: Eastern Europe Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 103: Eastern Europe Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 104: Eastern Europe Market Incremental $ Opportunity, 2024 to 2034
Figure 105: Eastern Europe Market Share Analysis by Country, 2024 & 2034
Figure 105: Eastern Europe Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 107: Eastern Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 108: Eastern Europe Market Share and BPS Analysis by Therapy, 2024 & 2034
Figure 109: Eastern Europe Market Y-o-Y Growth Projections by Therapy, 2024 to 2034
Figure 110: Eastern Europe Market Attractiveness Analysis by Therapy, 2024 to 2034
Figure 111: Eastern Europe Market Share and BPS Analysis by Drug Class, 2024 & 2034
Figure 112: Eastern Europe Market Y-o-Y Growth Projections by Drug Class, 2024 to 2034
Figure 113: Eastern Europe Market Attractiveness Analysis by Drug Class, 2024 to 2034
Figure 114: Eastern Europe Market Share and BPS Analysis by Organ, 2024 & 2034
Figure 115: Eastern Europe Market Y-o-Y Growth Projections by Organ, 2024 to 2034
Figure 116: Eastern Europe Market Attractiveness Analysis by Organ, 2024 to 2034
Figure 117: Eastern Europe Market Share and BPS Analysis by Age Group, 2024 & 2034
Figure 118: Eastern Europe Market Y-o-Y Growth Projections by Age Group, 2024 to 2034
Figure 119: Eastern Europe Market Attractiveness Analysis by Age Group, 2024 to 2034
Figure 120: Eastern Europe Market Share and BPS Analysis by Distribution Channel, 2024 & 2034
Figure 121: Eastern Europe Market Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034
Figure 122: Eastern Europe Market Attractiveness Analysis by Distribution Channel, 2024 to 2034
Figure 123: Eastern Europe Market Share and BPS Analysis by End User, 2024 & 2034
Figure 124: Eastern Europe Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 125: Eastern Europe Market Attractiveness Analysis by End User, 2024 to 2034
Figure 126: East Asia Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 127: East Asia Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 128: East Asia Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 129: East Asia Market Incremental $ Opportunity, 2024 to 2034
Figure 130: East Asia Market Share Analysis by Country, 2024 & 2034
Figure 131: East Asia Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 132: East Asia Market Attractiveness Analysis by Country, 2024 to 2034
Figure 133: East Asia Market Share and BPS Analysis by Therapy, 2024 & 2034
Figure 134: East Asia Market Y-o-Y Growth Projections by Therapy, 2024 to 2034
Figure 135: East Asia Market Attractiveness Analysis by Therapy, 2024 to 2034
Figure 136: East Asia Market Share and BPS Analysis by Drug Class, 2024 & 2034
Figure 137: East Asia Market Y-o-Y Growth Projections by Drug Class, 2024 to 2034
Figure 138: East Asia Market Attractiveness Analysis by Drug Class, 2024 to 2034
Figure 139: East Asia Market Share and BPS Analysis by Organ, 2024 & 2034
Figure 140: East Asia Market Y-o-Y Growth Projections by Organ, 2024 to 2034
Figure 141: East Asia Market Attractiveness Analysis by Organ, 2024 to 2034
Figure 142: East Asia Market Share and BPS Analysis by Age Group, 2024 & 2034
Figure 143: East Asia Market Y-o-Y Growth Projections by Age Group, 2024 to 2034
Figure 144: East Asia Market Attractiveness Analysis by Age Group, 2024 to 2034
Figure 145: East Asia Market Share and BPS Analysis by Distribution Channel, 2024 & 2034
Figure 146: East Asia Market Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034
Figure 147: East Asia Market Attractiveness Analysis by Distribution Channel, 2024 to 2034
Figure 148: East Asia Market Share and BPS Analysis by End User, 2024 & 2034
Figure 149: East Asia Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 150: East Asia Market Attractiveness Analysis by End User, 2024 to 2034
Figure 151: South Asia & Pacific Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 152: South Asia & Pacific Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 153: South Asia & Pacific Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 154: South Asia & Pacific Market Incremental $ Opportunity, 2024 to 2034
Figure 155: South Asia & Pacific Market Share Analysis by Country, 2024 & 2034
Figure 156: South Asia & Pacific Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 157: South Asia & Pacific Market Attractiveness Analysis by Country, 2024 to 2034
Figure 158: South Asia & Pacific Market Share and BPS Analysis by Therapy, 2024 & 2034
Figure 159: South Asia & Pacific Market Y-o-Y Growth Projections by Therapy, 2024 to 2034
Figure 160: South Asia & Pacific Market Attractiveness Analysis by Therapy, 2024 to 2034
Figure 161: South Asia & Pacific Market Share and BPS Analysis by Drug Class, 2024 & 2034
Figure 162: South Asia & Pacific Market Y-o-Y Growth Projections by Drug Class, 2024 to 2034
Figure 163: South Asia & Pacific Market Attractiveness Analysis by Drug Class, 2024 to 2034
Figure 164: South Asia & Pacific Market Share and BPS Analysis by Organ, 2024 & 2034
Figure 165: South Asia & Pacific Market Y-o-Y Growth Projections by Organ, 2024 to 2034
Figure 166: South Asia & Pacific Market Attractiveness Analysis by Organ, 2024 to 2034
Figure 167: South Asia & Pacific Market Share and BPS Analysis by Age Group, 2024 & 2034
Figure 168: South Asia & Pacific Market Y-o-Y Growth Projections by Age Group, 2024 to 2034
Figure 169: South Asia & Pacific Market Attractiveness Analysis by Age Group, 2024 to 2034
Figure 170: South Asia & Pacific Market Share and BPS Analysis by Distribution Channel, 2024 & 2034
Figure 171: South Asia & Pacific Market Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034
Figure 172: South Asia & Pacific Market Attractiveness Analysis by Distribution Channel, 2024 to 2034
Figure 173: South Asia & Pacific Market Share and BPS Analysis by End User, 2024 & 2034
Figure 174: South Asia & Pacific Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 175: South Asia & Pacific Market Attractiveness Analysis by End User, 2024 to 2034
Figure 176: MEA Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 177: MEA Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 178: MEA Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 179: MEA Market Incremental $ Opportunity, 2024 to 2034
Figure 180: MEA Market Share Analysis by Country, 2024 & 2034
Figure 181: MEA Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 182: MEA Market Attractiveness Analysis by Country, 2024 to 2034
Figure 183: MEA Market Share and BPS Analysis by Therapy, 2024 & 2034
Figure 184: MEA Market Y-o-Y Growth Projections by Therapy, 2024 to 2034
Figure 185: MEA Market Attractiveness Analysis by Therapy, 2024 to 2034
Figure 186: MEA Market Share and BPS Analysis by Drug Class, 2024 & 2034
Figure 187: MEA Market Y-o-Y Growth Projections by Drug Class, 2024 to 2034
Figure 188: MEA Market Attractiveness Analysis by Drug Class, 2024 to 2034
Figure 189: MEA Market Share and BPS Analysis by Organ, 2024 & 2034
Figure 190: MEA Market Y-o-Y Growth Projections by Organ, 2024 to 2034
Figure 191: MEA Market Attractiveness Analysis by Organ, 2024 to 2034
Figure 192: MEA Market Share and BPS Analysis by Age Group, 2024 & 2034
Figure 193: MEA Market Y-o-Y Growth Projections by Age Group, 2024 to 2034
Figure 194: MEA Market Attractiveness Analysis by Age Group, 2024 to 2034
Figure 195: MEA Market Share and BPS Analysis by Distribution Channel, 2024 & 2034
Figure 196: MEA Market Y-o-Y Growth Projections by Distribution Channel, 2024 to 2034
Figure 197: MEA Market Attractiveness Analysis by Distribution Channel, 2024 to 2034
Figure 198: MEA Market Share and BPS Analysis by End User, 2024 & 2034
Figure 199: MEA Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 200: MEA Market Attractiveness Analysis by End User, 2024 to 2034
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How big is the solid organ transplant (SOT) market in 2024?
The global market for solid organ transplants is forecasted to reach US$ 4.9 billion in 2024.
What is the projection for the solid organ transplant market?
Worldwide revenue from solid organ transplants is projected to reach US$ 7.88 billion by 2034-end.
At what rate is the demand for solid organ transplants projected to increase?
Demand for solid organ transplants is forecasted to rise at 4.9% CAGR through 2034.
Who are the leading players in the global market?
Key market players are Astellas Pharma US, Inc., Bristol-Myers Squibb Company, and AbbVie Inc.
Which drug class accounts for a higher market share?
Calcineurin inhibitors are expected to hold 38.8% market share in 2034.
At what rate is the market projected to advance in South Korea?
The market in South Korea is forecasted to rise at 5.3% CAGR through 2034.
Which region is projected to hold a higher share of the global market?
North America is projected to account for 44.5% of the global market share by 2034.
Solid Organ Transplant (SOT) Market